May 7, 2025 Safe harbor & forward looking statements This communication contains forward-looking statements related to Sunrun (the "Company") within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements related to: the Company's financial and operating guidance and expectations; the Company's business plan, trajectory ...

Financial Performance - Net income attributable to common shareholders was $3085 thousand, a significant increase compared to a net loss of $26341 thousand in the year-ago period[10] - Operating FFO was $8282 thousand, down from $59801 thousand in the previous year[10] - The company recorded $8400 thousand in other property revenues related to a condemnation proceeding in Florida[10] Portfolio Operations - The leased rate was 89.8% as of March 31, 2025, compared to 91.7% at March 31, 2024[10] - The commenced rate was 89.4% at the end of the quarter, slightly down from 89.8% year-over-year[10] - The company executed 5 new leases and 17 renewals, totaling 75000 square feet during the quarter[10] - Cash renewal leasing spreads were 3.4% for the first quarter of 2025[10] Asset Sales and Strategy - SITE Centers has two properties under contract for sale with an aggregate price of $95300 thousand[6] - Additional properties are in various stages of contract negotiations or marketing, exceeding $350000 thousand[6] Capital Structure - The market value per share was $12.84 as of March 31, 2025, compared to $15.29 at the end of 2024[30] - Common shares equity totaled $673394 thousand[30] - Net debt was $332013 thousand[30]

Q1 2025 Financial Performance - Total revenue reached $82.3 million, a 5.5% increase year-over-year [4] - Total constant currency revenue was also $82.3 million, representing a 7.1% increase [4] - Net loss was $(6.174) million, an improvement compared to $(14.578) million in the same period last year [5] - Adjusted EBITDA (non-GAAP) was $36 thousand, a significant increase from $(7.642) million in the prior year [7] - Adjusted net loss was $(2.888) million, compared to $(10.422) million in the prior year [9] Revenue Breakdown by Category - Business-to-business domestic sales contributed $21.5 million, a 29.9% increase, representing 26.1% of total revenue [4] - Business-to-business international sales amounted to $32.0 million, a 22.9% increase, accounting for 38.9% of total revenue [4] - Direct-to-consumer domestic sales were $15.0 million, a decrease of 26.8%, making up 18.2% of total revenue [4] - Rental revenue was $13.8 million, a decrease of 7.5%, representing 16.8% of total revenue [4] Operating Expenses - Total operating expenses were $44.028 million, a decrease from $50.645 million in the prior year [5] - Research and development expenses decreased to $4.034 million from $6.578 million [5] - Sales and marketing expenses decreased to $23.757 million from $26.936 million [5] - General and administrative expenses decreased to $16.237 million from $17.131 million [5]

Q1 2025 Earnings May 7, 2025 Safe Harbor This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding: expectations regarding our future results of operations and financial position, margin expansion and overall growth, including, without limita ...

Investor Presentation May 2025 © 2025 ON24, Inc. | Confidential Legal Disclaimer This presentation contains "forward-looking statements" under applicable securities laws. Such statements can be identified by words such as: "outlook," "expect," "convert," "believe," "plan," "future," "may," "should," "will," and similar references to future periods. Forward-looking statements include express or implied statements regarding our expected financial and operating results, the execution of our capital return prog ...

Company Strategy & Focus - Amphastar operates with a "Three-H Focus" on High Quality, High Efficiency, and High Technology to drive high net income margins[8, 15, 17] - The company employs a dual-strategy growth model, combining organic pipeline development with strategic acquisitions[8, 13, 14] - Amphastar is shifting its pipeline towards proprietary and biosimilar drugs, projecting a change from 63% generic, 16% biosimilar, and 21% proprietary in 2021 to 15% generic, 35% biosimilar, and 50% proprietary in 2026[19, 20] Financial Performance & R&D - Amphastar's revenue increased from $295 million in 2018 to $732 million in 2024[15] - Adjusted net income margin grew from 3.5% in 2018 to 27.4% in 2024[15] - The company has invested approximately $351 million in self-funded R&D over the past 5 years[26] Key Products & Pipeline - Baqsimi® sales are projected to reach a peak of $250 million to $275 million, with an estimated $2.00 to $2.50 incremental adjusted EPS at peak[47, 52] - Primatene MIST® annual sales surpassed $100 million in 2024[55] - The company has several ANDA and BLA pipeline candidates, including AMP-007 (inhalation) with a market size of +$1.5 billion and AMP-028 (biosimilar) with a market size of +$2.0 billion[29]

Financial Performance - Verra Mobility's Q1 2025 total revenue reached $223 million, a 6% year-over-year increase[6, 12] - Adjusted EBITDA for Q1 2025 was $95 million, representing a 3% year-over-year growth[6, 14] - Adjusted EPS for Q1 2025 was $030, an 11% year-over-year increase[6, 15] - Free Cash Flow for Q1 2025 was $42 million, a 108% year-over-year increase[6, 17] Segment Performance - Commercial Services revenue increased by 6% year-over-year, driven by increased travel volume, product adoption, and tolling activity[10, 25] - Government Solutions service revenue grew by 4% year-over-year, with 7% growth outside of New York City[10, 28] - Parking Solutions SaaS-only revenue grew 5% year-over-year, while total revenue remained flat due to a decline in installation and professional services[10, 31] Financial Outlook and Balance Sheet - The company reaffirmed its 2025 financial outlook, projecting total revenue between $925 million and $935 million[10, 40] - Adjusted EBITDA is expected to be between $410 million and $420 million, representing approximately 3% year-over-year growth[40] - Adjusted EPS is projected to be between $130 and $135, reflecting approximately 8% year-over-year growth[40] - Free Cash Flow is expected to be between $175 million and $185 million, with a conversion rate of approximately 43%[40] - As of March 31, 2025, Verra Mobility had $108 million in cash and cash equivalents and $75 million available under its revolving credit facility, resulting in $183 million in total available liquidity[33]

Q1 2025 Financial Results May 7, 2025 1 Safe Harbor Statement/Trademarks There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including, among others, the availability of USG funding for contracts related to procurement of our medical countermeasure ("MCM") products, including CYFENDUS® (Anthrax Vaccine Adsorbed (AVA) Adjuvanted), previously known as AV7909, and ACAM2000® (Smallpox (Vaccinia) Vaccine, Live), ...

Earnings Call Supplemental Slides First Quarter 2025 John Sabino, Chief Executive Officer John Collins, Chief Financial Officer and Chief Operating Officer May 7, 2025 Disclaimer This presentation as well as the associated earnings release and earnings call contain and will contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by o ...

Q1 2025 INVESTOR PRESENTATION reported on May 7, 2025 Elevating Essential Products Leading producer of specialty alcohols and high quality ingredients 1 Safe Harbor Statement Statements and information contained in this communication that refer to or include Alto Ingredients' estimated or anticipated future results or other non- historical expressions of fact are forward-looking statements that reflect Alto Ingredients' current perspective of existing trends and information as of the date of the communicati ...